Adjuvant chemotherapy for adenocarcinoma of the lung--is the standard of care ready for change?
Diasio
Robert B
RB
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000601:surgery; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage* / Q000378:metabolism / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy / Q000378:metabolism; D017024:Chemotherapy, Adjuvant; D042943:Dihydrouracil Dehydrogenase (NADP) / Q000037:antagonists & inhibitors / Q000378:metabolism; D004338:Drug Combinations; D005472:Fluorouracil / Q000378:metabolism; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000601:surgery; D011355:Prodrugs / Q000008:administration & dosage* / Q000378:metabolism; D005641:Tegafur / Q000008:administration & dosage* / Q000378:metabolism; D014498:Uracil / Q000008:administration & dosage* / Q000378:metabolism
D004338:Drug Combinations; D011355:Prodrugs; D005641:Tegafur; D014498:Uracil; D042943:Dihydrouracil Dehydrogenase (NADP); D005472:Fluorouracil